Currently holds a position at Apellis Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Chief Commercial Officer | Apellis Pharmaceuticals Inc | Nov. 20, 2018 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-02-13 | 2024-02-12 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
1,148
-1.2%
67.7777,796 USD |
1,148 -1.2% | 67.77 | 77,796 USD | |
2024-01-31 | 2024-01-29 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
906
-1.0%
64.1458,109 USD |
906 -1.0% | 64.14 | 58,109 USD | |
2024-01-23 | 2024-01-22 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
3,413
-3.5%
65.00221,831 USD |
3,413 -3.5% | 65.00 | 221,831 USD | |
2024-01-17 | 2024-01-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
2,235
-2.2%
66.81149,317 USD |
2,235 -2.2% | 66.81 | 149,317 USD | |
2023-05-04 | 2023-05-03 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
5,000
-6.2%
82.71413,550 USD |
5,000 -6.2% | 82.71 | 413,550 USD | |
2023-03-07 | 2023-03-03 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
5,000
-6.2%
63.84319,200 USD |
5,000 -6.2% | 63.84 | 319,200 USD | |
2023-02-06 | 2023-02-03 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
5,000
-6.9%
55.85279,250 USD |
5,000 -6.9% | 55.85 | 279,250 USD | |
2023-01-05 | 2023-01-03 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
5,000
-10.4%
50.70253,500 USD |
5,000 -10.4% | 50.70 | 253,500 USD | |
2022-12-07 | 2022-12-05 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
5,000
-10.4%
50.38251,900 USD |
5,000 -10.4% | 50.38 | 251,900 USD | |
2022-11-07 | 2022-11-03 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
5,000
-10.4%
58.54292,700 USD |
5,000 -10.4% | 58.54 | 292,700 USD | |
2022-09-07 | 2022-09-06 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
5,000
-10.4%
60.38301,900 USD |
5,000 -10.4% | 60.38 | 301,900 USD | |
2022-08-16 | 2022-08-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
12,500
-22.6%
69.00862,500 USD |
12,500 -22.6% | 69.00 | 862,500 USD | |
2022-08-12 | 2022-08-11 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
12,500
-22.6%
67.00837,500 USD |
12,500 -22.6% | 67.00 | 837,500 USD | |
2022-08-09 | 2022-08-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
12,500
-22.6%
65.00812,500 USD |
12,500 -22.6% | 65.00 | 812,500 USD | |
2022-08-04 | 2022-08-03 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
5,000
-11.7%
56.43282,150 USD |
5,000 -11.7% | 56.43 | 282,150 USD |